BioWorld - Tuesday, March 10, 2026

BioWorld Science

April 19, 2022

View Archived Issues

IKZF2 degrader PLX-4107 shows promise as cancer immunotherapeutic

Read More

New platform for rapid development of patient-specific APECs for ovarian carcinoma

Read More

Anti-CLDN18.2/CD47 antibody PT-886 shows antitumoral activity in model of pancreatic cancer

Read More

INBRX-130: a novel bispecific antibody targeting 5T4 and CD3

Read More

Shanghai Ringene Biopharma discovers S-adenosylmethionine synthase isoform type-2 inhibitors

Read More

New Bruton tyrosine kinase inhibitors synthesized at GenFleet Therapeutics

Read More

Medshine Discovery presents new PTPN11 inhibitors

Read More

New MAP4K1 inhibitors identified at Shenzhen Ionova Life Science

Read More

Shanghai Meiyue Biotech Development patents pantetheinase inhibitors

Read More

Cellectis details activity of allogeneic CAR-T cells targeting CD20 and CD22: UCART20x22

Read More

Microbe-sensing mechanism via neuronal Nod2 regulates appetite and metabolism

Read More

Biocytogen and CtM Biotech to develop novel immunotherapy candidates

Read More

Bridge Biotherapeutics inlicenses Shaperon's IPF candidate BBT-209

Read More

Targeting beta-catenin C-terminal domain/S1PR1 axis for vascular remodeling

Read More

CFT-1946 shows promising efficacy in BRAF-driven cancer models

Read More

ASC-11 demonstrates efficacy against different SARS-CoV-2 variants

Read More